NDC 0338-9540-01 - Clinolipid
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0338-9540
- Requested NDC
- 0338-9540-01
- Package NDCs from labels
- 0338-9540-04, 0338-9540-08, 0338-9540-03, 0338-9540-07, 0338-9540-02, 0338-9540-06, 0338-9540-01, 0338-9540-05
- Manufacturer
- Baxter Healthcare Corporation | Baxter SA | Baxter R&D Europe SPRL
- Effective date
- 2025-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clinolipid - Baxter Healthcare Corporation | Baxter SA | Baxter R&D Europe SPRL | Baxter Healthcare Corporation | Baxter SA | Baxter R&D Europe SPRL | 2025-07-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0338-9540-01 | Clinolipid | 100 mL in 1 BAG | INJECTION, EMULSION | 100 | 23 | |
| 0338-9540-02 | Clinolipid | 250 mL in 1 BAG | INJECTION, EMULSION | 250 | 23 | |
| 0338-9540-03 | Clinolipid | 500 mL in 1 BAG | INJECTION, EMULSION | 500 | 23 | |
| 0338-9540-04 | Clinolipid | 1000 mL in 1 BAG | INJECTION, EMULSION | 1000 | 23 | |
| 0338-9540-05 | Clinolipid | 15 in 1 CARTON | INJECTION, EMULSION | 15 | 23 | |
| 0338-9540-06 | Clinolipid | 10 in 1 CARTON | INJECTION, EMULSION | 10 | 23 | |
| 0338-9540-07 | Clinolipid | 12 in 1 CARTON | INJECTION, EMULSION | 12 | 23 | |
| 0338-9540-08 | Clinolipid | 6 in 1 CARTON | INJECTION, EMULSION | 6 | 23 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0338-9540-01 | ML - Milliliter | 0338-9540 | 7ed264c3-e2fc-4169-b66f-9c0136b386d4 | 1 | 2019-07-02 |
| 0338-9540-02 | ML - Milliliter | 0338-9540 | b0b2f114-43ed-4b3c-858a-fec30ab85a48 | 1 | 2019-07-02 |
| 0338-9540-03 | ML - Milliliter | 0338-9540 | 90126cb2-8c21-4136-9e98-20694d29b4e1 | 1 | 2019-07-02 |
| 0338-9540-04 | ML - Milliliter | 0338-9540 | a57fe463-722e-4640-b04d-e1df0e6a5044 | 1 | 2019-07-02 |
| 0338-9540-05 | ML - Milliliter | 0338-9540 | 7672dc61-4f3a-43f1-8e52-18a985efdc9a | 1 | 2019-07-02 |
| 0338-9540-06 | ML - Milliliter | 0338-9540 | 9b40769c-3de8-4068-8003-e0bc77f481da | 1 | 2019-07-02 |
| 0338-9540-07 | ML - Milliliter | 0338-9540 | 5d9c6ecc-5f82-44af-979c-1cbf6ccd84ff | 1 | 2019-07-02 |
| 0338-9540-08 | ML - Milliliter | 0338-9540 | c02b0c24-3a15-4093-83f0-74a9953ec262 | 1 | 2019-07-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| OLIVE OIL | ACTIVE INGREDIENT | 6UYK2W1W1E | CLINOLIPID (OLIVE OIL AND SOYBEAN OIL) INJECTION, EMULSION [BAXTER HEALTHCARE CORPORATION] | 1 | |
| SOYBEAN OIL | ACTIVE INGREDIENT | 241ATL177A | CLINOLIPID (OLIVE OIL AND SOYBEAN OIL) INJECTION, EMULSION [BAXTER HEALTHCARE CORPORATION] | 1 | |
| OLIVE OIL | ACTIVE MOIETY | 6UYK2W1W1E | CLINOLIPID (OLIVE OIL AND SOYBEAN OIL) INJECTION, EMULSION [BAXTER HEALTHCARE CORPORATION] | 1 | |
| SOYBEAN OIL | ACTIVE MOIETY | 241ATL177A | CLINOLIPID (OLIVE OIL AND SOYBEAN OIL) INJECTION, EMULSION [BAXTER HEALTHCARE CORPORATION] | 1 | |
| EGG PHOSPHOLIPIDS | INACTIVE INGREDIENT | 1Z74184RGV | CLINOLIPID (OLIVE OIL AND SOYBEAN OIL) INJECTION, EMULSION [BAXTER HEALTHCARE CORPORATION] | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | CLINOLIPID (OLIVE OIL AND SOYBEAN OIL) INJECTION, EMULSION [BAXTER HEALTHCARE CORPORATION] | 1 | |
| SODIUM OLEATE | INACTIVE INGREDIENT | 399SL044HN | CLINOLIPID (OLIVE OIL AND SOYBEAN OIL) INJECTION, EMULSION [BAXTER HEALTHCARE CORPORATION] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| WALGREEN GLYCERIN ADULT | GLYCERIN SUPPOSITORY | Walgreens | 20c44346-0b29-7364-e063-6294a90a648f | 2026-06-15 | Warnings | PDC6A3C0OX |
| WALGREENS GLYCERIN | GLYCERIN SUSPENSION | Walgreens | 20c44346-0b2b-7364-e063-6294a90a648f | 2026-06-15 | Warnings | PDC6A3C0OX |
| Equaline Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | United Natural Foods, Inc. dba UNFI | bf87824a-522d-46da-81b6-e30ea11a2235 | 2026-06-11 | Warnings | PDC6A3C0OX |
| Chloraseptic Sore Throat Max | PHENOL AND GLYCERIN | Prestige Brands Holdings, Inc. | 882c940c-b3c3-4aa4-8d64-e4260f066ff4 | 2026-06-08 | Warnings | PDC6A3C0OX |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | HyVee Inc | b867f691-7a13-4659-b664-06aa36899310 | 2026-06-03 | Warnings | PDC6A3C0OX |
| C-More Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | PROFOUND NUTRITION LIMITED | 78f04ecb-da5e-468c-81fe-70f7c26b76c2 | 2026-06-01 | Warnings | PDC6A3C0OX |
| Peep Club | GLYCERIN | Peep Club Eyecare Corp. | 513d1988-2827-28d8-e063-6294a90a8d1f | 2026-05-28 | Warnings | PDC6A3C0OX |
| Ripple | GLYCERIN, POVIDONE | CorneaCare Inc | 3b5ba197-d501-681e-e063-6294a90aefb5 | 2026-05-24 | Warnings | PDC6A3C0OX |
| Walgreens Adult Glycerin Laxative | GLYCERIN SUPPOSITORY | Walgreens | 5285403b-ab44-21a1-e063-6394a90a9fd0 | 2026-05-23 | Warnings | PDC6A3C0OX |
| HEMORRHOIDAL WITH LIDOCAINE | GLYCERIN, LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE, WHITE PETROLATUM | CVS PHARMACY, INC | 4d870c68-9e72-464e-b0b8-900d0d661e43 | 2026-05-14 | Warnings | PDC6A3C0OX |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, POTASSIUM SORBATE, RESORCINUM, SALICYLICUM ACIDUM, | Energique, Inc. | 2831d28e-9cf1-4a72-9c6c-bb014d059558 | 2026-05-06 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN SUPPOSITORIES | Neilmed Pharmaceuticals Inc. | 374a2ca3-ee04-09a7-e063-6394a90ab760 | 2026-05-05 | Warnings | PDC6A3C0OX |
| REFRESH TEARS PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 9e1cba7b-84ed-47f3-b19a-121992834350 | 2026-04-24 | Warnings | PDC6A3C0OX |
| Nut Antigens | ARSENICUM ALBUM, LYCOPODIUM CLAVATUM, PULSATILLA (PRATENSIS), SULPHUR, ALMOND (NUT), CASHEW (NUT), BLACK WALNUT (NUT), PECAN (NUT), COCONUT, OLEUM OLEA EUROPAEA, CHESTNUT (NUT), WATER CHESTNUT (NUT), PINENUT (NUT), MACADAMIA (NUT), PISTACHIO (NUT), PEANUT (NUT), ENGLISH WALNUT (NUT), BRAZIL NUT (NUT), HAZELNUT (NUT), CARYA ALBA | BioActive Nutritional, Inc. | fa2ac9d8-67e7-41b6-b57d-7b7cb29d0524 | 2026-04-23 | Warnings | 6UYK2W1W1E |
| Pure Eyes Sterile Eyes | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | SAMSON PHARMACEUTICAL | c0234e82-211f-4731-ac48-12db13b16e8a | 2026-04-21 | Warnings | PDC6A3C0OX |
| Artificial Tears Lubricant Eye Drops | GLYCERIN, PROPYLENE GLYCOL | CVS Pharmacy | 28297fee-8185-4869-8f39-5bfbf8bf8bfd | 2026-04-13 | Warnings | PDC6A3C0OX |
| blink boost | GLYCERIN | Bausch & Lomb Incorporated | e765c224-1718-488f-99b2-976eb60c1d63 | 2026-04-13 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Cream with Lidocaine | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Trifecta Pharmaceuticals Usa Llc | 4f1ef866-c4af-989b-e063-6294a90a148e | 2026-04-10 | Warnings | PDC6A3C0OX |
| WE FRESH Lubricating Eye Drops | GLYCERIN | Oculus Surgical, Inc. | 4f253b5d-001b-091e-e063-6394a90a9d39 | 2026-04-09 | Warnings | PDC6A3C0OX |
| Sore Throat | PHENOL GLYCERIN | Walgreens | 1e845299-178e-49ce-9d08-7e9d548a5a6d | 2026-04-09 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.